American Society of Interventional Pain Physicians | June 13, 2018
ASIPP Offers 4 Courses June 29 - 30 in Orlando

Introducing Advanced Neuromodulation Course!
This one day didactic and one day cadaver lab will be offered at the advanced level.

Attendance in the Neuromodulation Level is limited to 2 stations with just 4 physicians at each station.

The Neuromodulation Advanced Course will include the following procedures:
1. Spinal cord stimulator trial – Conventional leads
2. Spinal cord stimulator trial – Newer leads
3. Spinal cord stimulator implant
4. Spinal cord stimulator and DRG implant
5. Intrathecal Infusion System
6. Peripheral Nerve Stimulation 

HOTEL: Reservation Group Call-In Center
Toll Free: 1.866.360.7395
Local: 407.503.9276
Fax: 407.503.9208

HOTEL: Reservation Group Call-In Center
Toll Free: 1.866.360.7395
Local: 407.503.9276
Fax: 407.503.9208

HOTEL: Reservation Group Call-In Center
Toll Free: 1.866.360.7395
Local: 407.503.9276
Fax: 407.503.9208
Anthony Bourdain, Kate Spade’s death ignites concern about rising suicide rate

The deaths of chef-turned-TV host Anthony Bourdain and fashion designer Kate Spade this week has reminded Americans of the enormous toll of suicide, a growing problem that claims nearly 45,000 lives a year.
Suicide rates in the U.S. have risen nearly 30% since 1999, according to a report released Thursday from the Centers for Disease Control and Prevention. Suicides increased in both men and women, in all ethnic groups and in both urban and rural areas. Suicide and “self-harm,” a category that includes attempted suicides, cost the nation $70 billion a year in medical care and lost work time, the CDC says.
Nearly half of people who died by suicide had a known mental health condition, according to the CDC. Family members have given different accounts of Spade’s struggle. In media interviews, her sister, Reta Saffo, has said that she believes the designer suffered from bipolar disorder, also known as manic depression. The designer’s husband said in a statement that she “suffered from depression and anxiety for many years” and “was actively seeking help” before she died on Tuesday. 

Opioid epidemic: Turns out patients are happier when doctors lower their dose

A Kaiser Permanente  study  of nearly 2,500 patients who used high doses of opioids for at least six months showed that reducing their opioid use did not lower their satisfaction with care -- which could have positive reimbursement implications for hospitals.
Patient satisfaction is one of the criteria the Centers for Medicare and Medicaid Services looks at to determine reimbursement -- the more patients report being happy, the more money hospitals receive -- and this reflects a broader wave of consumerism. With the advent of online ratings sites and social media,  patients wield considerable power , and increasingly are voting for their preferred providers with their wallets. 
Because of that, physicians are often concerned they'll receive lower satisfaction scores if they reduce opioids for patients who are accustomed to high doses to manage chronic pain. The results showed they needn't be.

Perioperative Lidocaine May Reduce Risk for Chronic Postsurgical Pain

Perioperative lidocaine infusions may reduce the likelihood of developing chronic postsurgical pain, according to a systematic review and meta-analysis published in  Pain .
The researchers conducted a systemic literature search of major medical databases from inception through October 2017. The study included 6 trials in which adults reported chronic postsurgical pain after undergoing noncardiac surgery (n=420). In these trials, study participants had no baseline pain and were randomly assigned to receive  perioperative lidocaine infusion  or placebo.

Interventional Pain Management Reports is an Open Access online journal, a peer-reviews journal dedicated to the publication of case reports, brief commentaries and reviews and letters to the editor. It is a peer-reviewed journal written by and directed to an audience of interventional pain physicians, clinicians and basic scientists with an interest in interventional pain management and pain medicine. 

Interventional Pain Management Reports is an official publication of the American Society of Interventional Pain Physicians (ASIPP) and is a sister publication of Pain Physician . Interventional Pain Management Reports Interventional Pain Management Reports is an open access journal, available online with free full manuscripts.  

The benefits of publishing in an open access journal that has a corresponding
print edition journal are:  
  • Your article will have the potential to obtain more citations.
  • Your article will be peer-reviewed and published faster than other journals.
  • Your article can be read by a potentially much larger audience compared with traditional subscription-only journals.  
  • Open Access journals are FREE to view, download and to print.

So submit today your:
  • Case Reports
  • Technical Reports
  • Editorials
  • Short Perspectives

Essentials of Interventional Techniques in Managing Chronic Pain Available for Order!
  • Comprehensive textbook of interventional techniques in managing chronic pain
  • Covers spinal interventional techniques, peripheral nerve blocks, sympathetic interventional techniques, soft tissue and joint injections and implantables
  • Step-by-step guidance backed up by the latest evidence

This comprehensive review covers the full and latest array of interventional techniques for managing chronic pain. Chapters are grouped by specific treatment modalities that include spinal interventional techniques, nonspinal and peripheral nerve blocks, sympathetic interventional techniques, soft tissue and joint injections, and implantables. Practical step-by-step and evidence-based guidance is given to each approach in order to improve the clinician's understanding. Innovative and timely, Essentials of Interventional Techniques in Managing Chronic Pain is a critical resource for anesthesiologists, neurologists, and rehabilitation and pain physicians.

FBI raids Louisville-area doctors offices

The FBI and other law-enforcement authorities raided several Louisville-area doctors offices on Tuesday, including at least two locations of Bluegrass Pain Consultants. reports  that five business were raided, including Bluegrass Pain Consultants offices on Dutchmans Parkway and in La Grange.  The Courier Journal reports  that the Bluegrass Pain office on Champion Farms Drive, near Springhurst Town Center, also was raided.
Representatives of the FBI, the U.S. Drug Enforcement Administration, Kentucky State Police and the Indiana Attorney General's Office participated in the Dutchmans Parkway Bluegrass Pain raid, according to WDRB.
That office was closed, according to the report, with a sign indicating that it would reopen today.

New Charges in Neurologist Referral Kickback Scheme
A Bergen County neurologist indicted last year as part of a statewide medical kickback scheme is facing additional charges in a new superseding indictment announced by the state's Attorney General's Office.
The superseding indictment alleges Dr. Terry Ramnanan, 65, fraudulently billed insurance carriers for more than 637 medical procedures totaling $682,000 as part of a kickback scheme, it was stated in a news release.
The Bergen County neurologist, who operates the Interventional Spine and Pain Treatment Center facility in Paramus, now faces additional charges of health care claims fraud, misconduct by a corporate official, and other second-degree offenses, according to the release.

Pain physician faces insurance fraud, perjury after referring workers comp cases to ASC, lab he owned: 4 key notes

Sanjoy Banerjee, MD, a pain physician in Corona, Calif., has been charged with workers compensation insurance fraud and perjury by the Riverside County District Attorney .
Here are four things to know:
1. Dr. Banerjee is accused of billing workers compensation for more than $180,000 in urine toxicology testing and epidural injections he illegally self-referred to a laboratory and office-based surgical center he owned. He is the owner of Rochester Imperial Surgical Center in Wildomar, Calif.
2. Previously, Dr. Banerjee signed five doctor's reports declaring under penalty of perjury that he didn't self-refer the patients to his lab and surgical center.
3. On May 29, Dr. Banerjee was charged with two counts of insurance fraud and five counts of perjury; he will enter his plea July 7 at his arraignment.

May/June 2018 Issue Features

Systematic Reviews
  • Role of Unilateral Balloon Kyphoplasty for OVCSF
Comprehensive Review
  • Patters, Changes, and Trends in Prescription Opioid Dispensing in Canada
  • Stem Cells for the Treatment of Knee Osteoarthritis
Randomized Trials
  • Effect of Different Volumes on Pain Relief in Patients Receiving Fluoroscopic Guided Interlaminar Lumbar Epidural Steroid Injections
  • Noninferiority Trial Comparing Upper and Lower One-Third Joint Approaches for SI Join Injections
  • Efficacy and Safety of Bone-filling Mesh Container and Simple Percutaneous Balloon Kyphoplasty


District Court Enters Permanent Injunction Against Mississippi Compounding Pharmacy and Two of its Officers to Prevent Distribution of Adulterated Drugs
WASHINGTON – The U.S. District Court for the Northern District of Mississippi entered a consent decree of permanent injunction against defendants Delta Pharma, Inc. (Delta Pharma), its President, Dr. Tommy T. Simpson, and its Vice President and Pharmacist in Charge, Charles Michael Harrison, to prevent the distribution of adulterated drugs in violation of federal law, the Department of Justice announced today.  
The entered permanent injunction stems from a complaint the Department filed in the U.S. District Court for the Northern District of Mississippi on June 4, 2018, at the request of the U.S. Food and Drug Administration (FDA). The complaint alleged, among other things, that the defendants distributed adulterated drugs in interstate commerce.  
As part of the permanent injunction, defendants are enjoined from manufacturing, holding, or distributing any drugs manufactured from their facility unless they comply with specific remedial measures. Those measures include submitting a plan to FDA, which will provide for an independent expert to conduct inspection(s) of defendants’ facility and ensuring that defendants implement all recommended corrective actions. In addition, the defendants must report to FDA the actions they have taken to correct all insanitary conditions and deviations from current good manufacturing practice brought to their attention by the FDA or defendants’ expert. The permanent injunction provides that defendants cannot resume manufacturing, holding, and distributing such drugs until FDA notifies them in writing that they appear to be in compliance with the ordered remedial measures.  


Mississippi Physician Sentenced to Over Three Years in Prison for Role in $3 Million Compounding Pharmacy Fraud Scheme
A Biloxi, Mississippi physician was sentenced today to 42 months in prison for his involvement in a $3 million compounding pharmacy fraud scheme. 
Acting Assistant Attorney General John P. Cronan of the Justice Department’s Criminal Division; U.S. Attorney D. Michael Hurst Jr. of the Southern District of Mississippi; Special Agent in Charge Christopher Freeze of the FBI’s Jackson, Mississippi Field Division; Acting Special Agent in Charge Thomas J. Holloman III of IRS Criminal Investigation’s (IRS-CI) New Orleans Field Office and Special Agent in Charge John F. Khin of the Defense Criminal Investigative Service’s (DCIS) Southeast Field Office made the announcement.
Albert Diaz, M.D., was sentenced by U.S. District Judge Keith Starrett of the Southern District of Mississippi. Restitution to TRICARE and other insurance companies will be determined at a later date. On March 2 after a five-day jury trial, Diaz was convicted of one count of conspiracy to commit health care fraud and wire fraud, four counts of wire fraud, one count of conspiracy to distribute and dispense a controlled substance, four counts of distributing and dispensing a controlled substance, one count of conspiracy to falsify records in a federal investigation and five counts of falsification of records in a federal investigation. 


Health Care CEO and Four Physicians Charged in Superseding Indictment in Connection with $200 Million Health Care Fraud Scheme Involving Unnecessary Prescription of Controlled Substances and Harmful Injections
A CEO and four physicians were charged today in a superseding indictment as part of an investigation into a $200 million health care fraud scheme that involved a network of Michigan and Ohio pain clinics, laboratories and other medical providers. The superseding indictment returned yesterday charges an additional wire fraud conspiracy, adds an additional count of money laundering, and contains new allegations regarding the distribution of over 4.2 million medically unnecessary dosage units of controlled substances and the administration of medically unnecessary injections that resulted in patient harm.    
Mashiyat Rashid, 37, of West Bloomfield, Michigan; Spilios Pappas, 61, of Monclova, Ohio; Joseph Betro, 57, of Novi, Michigan; Tariq Omar, 61, of West Bloomfield, Michigan; and Mohammed Zahoor, 51, also of Novi, were each charged with one count of conspiracy to commit health care fraud and wire fraud. Rashid was additionally charged with four counts of health care fraud, one count of conspiracy to defraud the United States and pay and receive health care kickbacks, one count of payment of kickbacks, one count of receipt of kickbacks and two counts of money laundering. Pappas, Betro, Omar, and Zahoor were each additionally charged with one count of health care fraud. All of the defendants were previously charged in an original indictment on July 6, 2017, which charged health care fraud and kickback conspiracies, substantive counts of health care fraud and payment or receipt of kickbacks, and one count of money laundering. The case is pending before U.S. District Judge Denise Page Hood of the Eastern District of Michigan. Trial has been scheduled to begin on July 31 before Judge Hood. 


State Society News 

July 19-22, 2018
FSIPP 2018 Annual Meeting, Conference, and Trade Show
Florida Society of Interventional Pain Physicians
One South County Road, Palm Beach, FL 33480
Click Here for more information

July 14, 2018
WVSIPP launches Regional Conference Series, WV PainCare
The West Virginia Society of Interventional Pain Physicians has created an educational series titled WV PainCare.
Huntington, WV - July 14, 2018
Lewisburg/Beckley, WV - October 20, 2018
Morgantown, WV - December 1, 2018
Click HERE for more information

Aug 17-19, 2018
Ohio and Kentucky SIPP Meeting
Click HERE for more information

July 12-14, 2019
GSIPP 2019 - 15th Annual Meeting & Pain Summit
The Cloister Hotel at Sea Island
Sea Island, GA
For more information, contact Karrie Kirwan at or Tara Morrison at or 770-613-0932.

Send in your state society meeting news to Holly Long,
ASIPP | Pain Physician Journal | Phone | Fax | Email